{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:34:23Z","timestamp":1791516863960,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007514","name":"University of Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vph.2022.107022","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T21:08:29Z","timestamp":1655759309000},"page":"107022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside"],"prefix":"10.1016","volume":"145","author":[{"given":"Matteo","family":"Mazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele De","family":"Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2022.107022_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2022.107022_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.vph.2022.107022_bb0015","first-page":"1502","article-title":"Portopulmonary hypertension: results from a 10-year screening","author":"Krowka","year":"2006","journal-title":"Algorithm."},{"key":"10.1016\/j.vph.2022.107022_bb0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/71.6.543","article-title":"Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients","volume":"71","author":"Castro","year":"1996","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.vph.2022.107022_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vph.2022.107022_bb0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec\u2019s cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2022.107022_bb0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9343(64)90066-X","article-title":"General and regional circulatory alterations in cirrhosis of the liver","volume":"37","author":"Kontos","year":"1964","journal-title":"Am. J. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9343(58)90322-X","article-title":"Circulatory changes in chronic liver disease","volume":"24","author":"Murray","year":"1958","journal-title":"Am. J. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2022.107022_bb0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2018.01.002","article-title":"Hepatopulmonary syndrome","volume":"69","author":"Fuhrmann","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2022.107022_bb0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(87)80123-7","article-title":"Coexistent pulmonary and portal hypertension: morphologic and clinical features","volume":"10","author":"Edwards","year":"1987","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2022.107022_bb0065","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01880-2018","article-title":"Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension","volume":"53","author":"Olsson","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vph.2022.107022_bb0070","first-page":"1355","article-title":"Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.vph.2022.107022_bb0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2022.107022_bb0085","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2016.12.014","article-title":"Survival in portopulmonary hypertension: outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry","volume":"36","author":"Sithamparanathan","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.vph.2022.107022_bb0090","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.vph.2022.107022_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/imj.14751","article-title":"Portopulmonary hypertension: prognosis and management in the current treatment era \u2013 results from the REHAP registry","volume":"51","author":"Lazaro Salvador","year":"2021","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.vph.2022.107022_bb0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.vph.2022.107022_bb0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.20459","article-title":"Hemodynamics and survival of patients with portopulmonary hypertension","volume":"11","author":"Kawut","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.vph.2022.107022_bb0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2022.107022_bb0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2022.107022_bb0120","first-page":"711","article-title":"Portopulmonary hypertension: from bench to bedside","volume":"0","author":"Thomas","year":"2020","journal-title":"Front Med Front."},{"key":"10.1016\/j.vph.2022.107022_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.vph.2022.107022_bb0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejim.2017.05.028","article-title":"Portopulmonary hypertension and hepatorenal syndrome. Two faces of the same coin","volume":"43","author":"Zardi","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vph.2022.107022_bb0140","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vph.2022.107022_bb0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0003319710369101","article-title":"Plasma cytokines and Portopulmonary hypertension in patients with cirrhosis waiting for Orthotopic liver transplantation","volume":"61","author":"Pellicelli","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.vph.2022.107022_bb0150","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.vph.2022.107022_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Gali\u00e9","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2022.107022_bb0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-8278(05)80584-7","article-title":"Elevated circulating plasma endothelin-1 concentrations in cirrhosis","volume":"19","author":"M\u00f8ller","year":"1993","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2022.107022_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s003950050170","article-title":"Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells","volume":"95","author":"Browatzki","year":"2000","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2022.107022_bb0170","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0175","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herv\u00e9","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.201912-2514LE","article-title":"BMP9\/10 in pulmonary vascular complications of liver disease","volume":"201","author":"Rochon","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0190","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension","volume":"199","author":"Nikolic","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(15)00544-5","article-title":"BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis","volume":"4","author":"Evans","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0200","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/hc3201.094152","article-title":"Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins","volume":"104","author":"Morrell","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2022.107022_bb0205","article-title":"Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur. Respir. J. England"},{"key":"10.1016\/j.vph.2022.107022_bb0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","article-title":"Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production: a gateway to pulmonary arterial hypertension","volume":"192","author":"Soon","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez-Roisin","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0220","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2022.107022_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hfc.2018.02.001","article-title":"The right heart-pulmonary circulation unit: physiopathology","volume":"14","author":"Naeije","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.vph.2022.107022_bb0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl."},{"key":"10.1016\/j.vph.2022.107022_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of pulmonary hypertension","volume":"53","author":"Frost","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0240","doi-asserted-by":"crossref","first-page":"106648","DOI":"10.1016\/j.vph.2020.106648","article-title":"Association of the European Society of cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery","volume":"125\u2013126","author":"Madonna","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2022.107022_bb0245","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0250","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.vph.2022.107022_bb0255","article-title":"Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to Transjugular intrahepatic portosystemic shunt","volume":"11","author":"Manguso","year":"2022","journal-title":"J Clin Med MDPI"},{"key":"10.1016\/j.vph.2022.107022_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cld.1031","article-title":"Hepatic venous pressure gradient","volume":"17","author":"Bochnakova","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.vph.2022.107022_bb0265","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.vph.2022.107022_bb0270","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachi\u00e9ry","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1665-2681(19)32023-X","article-title":"Beta blockers in portal hypertension. Are they really a good option?","volume":"5","author":"L\u00f3pez-M\u00e9ndez","year":"2006","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.vph.2022.107022_bb0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of \u03b2-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vph.2022.107022_bb0285","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2022.107022_bb0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2022.107022_bb0295","doi-asserted-by":"crossref","DOI":"10.15761\/JTS.1000182","article-title":"Hemostasis, bleeding and thrombosis in liver disease","volume":"3","author":"Flores","year":"2017","journal-title":"J Transl Sci"},{"key":"10.1016\/j.vph.2022.107022_bb0300","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2022.107022_bb0305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0315","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S2213-2600(19)30143-2","article-title":"Cardiopulmonary haemodynamics in portopulmonary hypertension","volume":"7","author":"Ghofrani","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vph.2022.107022_bb0320","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-006-1809-y","article-title":"Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension","volume":"41","author":"Wang","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.vph.2022.107022_bb0325","author":"Kalambokis"},{"key":"10.1016\/j.vph.2022.107022_bb0330","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30197","article-title":"Treatment barriers in portopulmonary hypertension","volume":"69","author":"AbuHalimeh","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.vph.2022.107022_bb0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2012.03.025","article-title":"Long-term hepatic safety of Ambrisentan in patients with pulmonary arterial hypertension","volume":"60","author":"Ben-Yehuda","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2022.107022_bb0340","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"Dubrock","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2022.107022_bb0345","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0037-1606251","article-title":"Portopulmonary hypertension","volume":"38","author":"Savale","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.vph.2022.107022_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28990","article-title":"Long-term outcome in liver transplantation candidates with portopulmonary hypertension","volume":"65","author":"Savale","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.vph.2022.107022_bb0355","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.25747","article-title":"Macitentan improves risk categorization for liver transplant mortality in patients with portopulmonary hypertension: a PORTICO study post hoc analysis","volume":"26","author":"Krowka","year":"2020","journal-title":"Liver Transpl."},{"key":"10.1016\/j.vph.2022.107022_bb0360","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-199802270-00001","article-title":"Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension","volume":"65","author":"Plotkin","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2022.107022_bb0365","article-title":"Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension","volume":"24","author":"Minder","year":"2021","journal-title":"Eur. Respir. J."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:20:35Z","timestamp":1761528035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189122000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":73,"alternative-id":["S1537189122000714"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2022.107022","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2022.107022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107022"}}